InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Levine Joshua, 首席执行官. Director active across 3 companies, notably Natus Medical INC. Aggregated, 8 disclosures have been published. Split: 2 buys · 2 sells. Total volume traded: €176k. History available since 17 June 2021. The latest transaction was disclosed on 14 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Levine Joshua
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
10,000 股@ US$4.75Common StockSEC:0001829126-26-008925:0
标准退出：2026年11月12日 (T+90)
37,387 股@ US$33.5083.0% 占其流量Common Stock, $0.001 par value per shareSEC:0000878526-22-000098:0
5,075 股0Common Stock, $0.001 par value per shareSEC:0000878526-22-000047:0
250,501 股0Common StockSEC:0001214659-21-011053:0
15,741 股@ US$3.960.17% mcap20.0% 占其流量Common StockSEC:0001214659-21-010427:0
15,741 股@ US$3.9666.7% 占其流量Common StockSEC:0001214659-21-010202:0
8,680 股@ US$3.6333.3% 占其流量Common StockSEC:0001214659-21-008821:0
标准退出：2021年11月16日 (T+90)
5,214 股@ US$28.779.3% 占其流量Common Stock, $0.001 par value per shareSEC:0000878526-21-000067:0
8 条申报中的 8 条
About Levine Joshua
Joshua Levine is the CEO and Director of NATUS MEDICAL INC and ACCURAY INC. As a leader, he is responsible for the strategic and operational direction of these companies. His expertise in the medical sector and ability to lead teams enable him to drive innovation and growth. He plays a key role in business development and stakeholder engagement.
